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NGF Signaling in Sensory Neurons:
Evidence that Early Endosomes Carry
NGF Retrograde Signals
transport of the NT bound to activated Trk (Watson et
al., 1999; Kuruvilla et al., 2000; Tsui-Pierchala and Ginty,
1999). Third, in vivo studies have shown that phosphory-
lated p-TrkA and downstream signaling proteins, includ-
ing Erk1/2, undergo retrograde axonal transport in the
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Departments of Pediatrics and Neurosurgery sciatic nerve (Ehlers et al., 1995; Johanson et al., 1995,
1996). Finally, NGF internalization was shown to be nec-Stanford University
1201 Welch Road essary for activation of CREB (Riccio et al., 1997).
There is also support for non-vesicle-mediated retro-MSLS Building
Stanford, California 94305 grade transport of NT signals. NGF application to the
distal axons of sympathetic neurons in compartmental-
ized cultures caused the extremely rapid appearance
within cell bodies of a number of phosphorylated pro-Summary
teins, including TrkA (Senger and Campenot, 1997). Us-
ing NGF covalently linked to beads, MacInnis and Cam-Target-derived NGF promotes the phenotypic mainte-
nance of mature dorsal root ganglion (DRG) nocicep- penot showed that retrograde signaling, leading to
survival of sympathetic neurons, did not require the in-tive neurons. Here, we provide in vivo and in vitro
evidence for the presence within DRG neurons of en- ternalization of NGF or activation of Erk1/2 (MacInnis
and Campenot, 2002). These results raised the possibil-dosomes containing NGF, activated TrkA, and signal-
ing proteins of the Rap1/Erk1/2, p38MAPK, and PI3K/ ity that NGF, acting at axon terminals, signals retro-
gradely through a mechanism that does not require theAkt pathways. Signaling endosomes were shown to be
retrogradely transported in the isolated sciatic nerve in formation or transport of signaling endosomes.
The most convincing support for vesicle-mediatedvitro. NGF injection in the peripheral target of DRG
neurons increased the retrograde transport of transport would be the isolation and characterization of a
signaling endosome from neurons. We undertook suchp-Erk1/2, p-p38, and pAkt in these membranes. Con-
versely, NGF antibody injections decreased the retro- studies in lumbar 4 and 5 (L4,5) DRG neurons and provide
evidence that NGF signaling is transmitted retrogradelygrade transport of p-Erk1/2 and p-p38. Our results are
evidence that signaling endosomes, with the charac- through axonal transport of early endosomes that contain
NGF, TrkA, and activated signaling proteins. In summary,teristics of early endosomes, convey NGF signals from
the target of nociceptive neurons to their cell bodies. our findings are evidence that NGF signaling is transmitted
retrogradely through axonal transport of early endosomes
that contain NGF, TrkA, and activated signaling proteins.Introduction
Through the production and release of neurotrophic fac- Results
tors, tissues regulate and maintain the structure and
function of the neurons that innervate them (Sofroniew NGF Injection in the Target of DRG Neurons
et al., 2001). Following release, neurotrophic factors dif- Elicited Increased Activation of MAPKs in Cell Bodies
fuse to presynaptic axon terminals where they bind and To show that NGF applied in the target of DRG neurons
activate their receptor(s) (Sofroniew et al., 2001). There increased activity of MAPKs in DRG cell bodies, we
is no consensus regarding how the signal(s) generated injected NGF (0.14 mg/kg in 100 l) into the right hind-
in axon terminals is conveyed retrogradely. Both vesicle- footpad of adult rats, using a method that prevented
mediated and non-vesicle-mediated signal transport systemic spread. The left hindfootpad was injected with
mechanisms have been suggested (Campenot et al., vehicle. Based on earlier studies (Stockel et al., 1975),
1994; Curtis et al., 1994; DiStefano and Curtis, 1994; we expected that 18–24 hr would be needed for NGF
Miller and Kaplan, 2002; Neet and Campenot, 2001; So- to be moved from the footpad to DRG cell bodies.
froniew et al., 2001; Watson et al., 1999). Twenty-four hours after footpad injection, cytoplasmic
There is evidence that some NT signals are moved in staining for p-Erk1/2 in DRG cell bodies (Figure 1A) could
vesicles, called signaling endosomes, in which the NT be observed on the vehicle treated side. Most staining
is bound to its activated receptor. First, NGF enhances was present in small- to medium-sized neurons (Figure
endocytosis of its TrkA receptors, and NGF is bound to 1E), a population whose size distribution matched that
TrkA in endosomes (Grimes et al., 1996). Indeed, in re- for TrkA-positive neurons (Figure 1K). NGF injection elic-
cent studies, clathrin-coated vesicles (CCVs) were found ited a 53% increase in p-Erk1/2 (Figure 1, compare pan-
to contain NGF bound to activated TrkA (p-TrkA) as well els A and B) in neurons of small to medium size (Figure
as activated components of the Ras-MAPK pathway, 1E) (OD units above background in cell bodies ranging
including Erk1/2 (Howe et al., 2001). Second, in compart- from 250 to 750 m2 (value  SEM [N  number of
mentalized cultures, NT treatment of distal processes of animals, n  number of profiles examined], Student’s t
sympathetic or sensory neurons induced the retrograde test; vehicle  53  0.2, [N  3, n  63]; NGF  81 
0.1, [N  3; n  55]; p  0.01).
NGF treatment also increased immunostaining for*Correspondence: jdd@stanford.edu
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Figure 1. NGF Injection in the Target of DRG Neurons Increased p-Erk1/2 and p-p38 Immunoreactivity in Cell Bodies and Axons
The diagram (upper right) depicts the sites at which data were collected. (A, F, and K) In saline-injected animals, immunoreactivity for p-Erk1/2,
p-p38, and TrkA was detected predominantly in neuron cell bodies of small to medium size (i.e., 250–750 m2). (B and G) NGF treatment increased
markedly p-Erk1/2 and p-p38 immunoreactivity in small- to medium-sized neurons. Relative to saline-injected controls (C and H), NGF injection
markedly increased immunostaining for p-pErk1/2 and p-p38 in axons (D and I). In (E), (J), and (K), neurons are plotted data for the cell body area
and optical density of immunostaining in individual DRG neurons. Neuron cell bodies that exhibited a nucleus in the plane of the section were
outlined, the area of their cell body was defined, and optical density (OD) was measured, all using NIH image. Scale bars, 100 m.
p-p38 in small- to medium-sized neurons DRG neuron to p-Erk1/2 in early endosomes (Wu et al., 2001); this
cell bodies (Figure 1, panel F versus panels G and J). suggested that early endosomes might serve to carry
There was extensive overlap between the size of p-p38- NGF signals from axon terminals to neuron cell bodies.
positive neurons and those positive for TrkA (Figure To test directly this possibility, we examined the subcel-
1K). As for p-Erk1/2, the dull staining seen in small- to lular distributions of several of the proposed compo-
medium-sized neurons in vehicle-treated animals (Fig- nents of an early endosome that could carry the NGF
ure 1F) was increased by NGF treatment, in this case signal (Wu et al., 2001). Endogenous (i.e., target-derived)
by about 95% (Figures 1G, and 1J). On the vehicle- NGF was detected in bright puncta distributed through-
injected side, the average OD was 40  0.3 (N  3; n  out the cytoplasm of DRG neurons (Figures 2A and 2B).
34), while on the NGF-injected side, it was 78 0.2 (N TrkA was partially colocalized with NGF (Figures 2A and
3; n  36) (p  0.01). Of note, p-p38 was colocalized 2B, merged and zoomed images). We examined the
extensively with p-Erk1/2, in that 77%  6.4% (SEM) of extent of colocalization (see Experimental Procedures)
p-p38-positive cell profiles were also positive for and found that, of the pixels positive for NGF, 50.5%
p-Erk1/2 (N  2 animals). (3.8% [SEM]; N  3 cells) were positive for TrkA; this
In both vehicle- and NGF-treated DRGs, we frequently extent of colocalization was significantly different from
noted bright immunostaining for p-Erk1/2 in profiles that
random (p 0.001). In addition, more than 82% of NGF-
appeared to rim neuron cell bodies (Figures 1A and 1B).
positive pixels were also positive for Rab5B, a markerWe ascribed these profiles to satellite cells, because
for early endosomes (81.7%  1.5%, N  3; p  0.001)we found immunostaining for BIP, a marker of the ER
(Figures 2C, 2D, and 2D) (Gorvel et al., 1991). Next we(Hamman, 1998), in the p-Erk1/2-positive rimming pro-
examined components of the Erk1/2 signaling pathway.files (data not shown). The apparent increase in p-Erk1/2
80.1% (3.8%, N  3, p  0.001) of p-Erk1/2-positivestaining in satellite cells that followed NGF treatment
pixels were also TrkA positive (Figure 2E) and 41.2% ofhas been seen previously (Averill et al., 2001).
TrkA-positive pixels (2.5%, N  3, p  0.001) were
also B-Raf positive (Figure 2F). In addition, p-Erk1/2 wasEvidence for MAPKs in Early Endosomes
colocalized with B-Raf (49.2% 3.9%, N 3, p 0.001)in DRG Cell Bodies
(Figure 2G) and Rab5B (66.4% 7.0%, N 3, p 0.001)p-Erk1/2 colocalized with TrkA and Rap1, a member of
the Ras family that mediates persistent NGF signaling (Figure 2H). Although the antibodies available did not
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Figure 2. Localization of NGF, TrkA, B-Raf, Rap1, p-Erk1/2, and Rab5B in DRG Cell Bodies and Axons
NGF and each of several components of NGF signaling pathways were examined (the first and second images in each series) as was the
extent to which they colocalized, as revealed by the presence of yellow puncta (Merged). A representative merged image is shown at higher
power (Zoom; an increase of 2- to 4-fold) to reveal staining in greater detail. To provide another demonstration of the extent of specific
colocalization, in (D) and (H) the merged image, replicated in the panel labeled 0, is compared to the merged images resulting from rotating
the image for the red channel with respect to the image from the green channel by 90, 180, or 270. Image rotation should identify only
random colocalization. Colocalization was present essentially only in the nonrotated images shown in panel 0. (A–I) Signaling proteins in
neuron cell bodies were localized using immunostaining and confocal microscopy. NGF with TrkA (A and B); NGF with Rab5B (C and D);
p-Erk1/2 with TrkA (E); B-Raf with TrkA (F); B-Raf with p-Erk1/2 (G); p-Erk1/2 with Rab5B (H). In (I), CGRP, a secreted peptide, did not
colocalized with p-Erk1/2. (J–M) Signaling proteins were examined in sciatic nerve axons. Trk and Rap-1 (J); p-Erk1/2 TrkA (K); p-Erk1/2 and
Rap-1 (L); p-Erk1/2 and Rab5B (M). Scale bars, 20 m. The results demonstrated are representative of observations in at least 20 cell bodies
or axons in each of two separate experiments.
allow for studies to colocalize TrkA and Rab5B, the ex- Effect of NGF Treatment on Activation of MAPKs
in Axons: Evidence that p-Erk1/2 Weretensive overlap of staining for these markers with
p-Erk1/2 suggests that they were colocalized. As a con- Present in Early Endosomes
If the NGF signal is moved retrogradely in signaling en-trol, we detected no colocalization of p-Erk1/2 and
CGRP (Figure 2I) (p  0.45), a neuropeptide marker of dosomes in axons, there should be evidence of the exis-
tence of these structures and of their induction by NGFthe secretory pathway (Gulbenkian et al., 1986). We also
noted colocalization of p-p38 with p-Erk1/2 (data not treatment. To assess this, we examined whether NGF
causes activation of p-Erk1/2 and p-p38 by immuno-shown). These data are evidence that in DRG neuron
cell bodies NGF, TrkA, and p-Erk1/2 as well as p-p38 staining studies on axons. p-Erk1/2 were present in
bright puncta distributed along axons in both vehicle-were present in early endosomes.
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Figure 3. Signaling Proteins and Rab5B Were Localized near Microtubules and Were Closely Associated with Elements of the Retrograde
Motor Complex: Retrograde Transport of Early Endosomes in DRG Axons
(A–C) In axons, p-Erk1/2-, Rab5B-, and TrkA-positive puncta were closely associated with microtubules, as marked by immunostaining for
tubulin. (D and E) Dynein and TrkA are found in close proximity and partially colocalize in axons and in neuron cell bodies. (F) p150Glued and
TrkA were extensively colocalized. The Zoom panel shows a portion of the merged panel. The results demonstrated in (A)–(F) are representative
of observations in at least 20 cell bodies or axons in each of two separate experiments. (G) DRG neurons in culture were transfected with a
Rab5A-GFP construct, and the pattern of movement of Rab5A was monitored using live imaging and confocal microsopy. In the upper images,
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and NGF-treated nerves (Figures 1C and 1D). NGF treat-
ment increased immunostaining intensity for p-Erk1/2.
The number of p-Erk1/2-positive puncta in NGF-treated
nerves was 167% 39% (SEM) (p 0.01, N 3 animals)
of the vehicle control. p-p38 was also present in puncta
in sensory axons (Figures 1H and 1I) (NGF treated was
191%  44% of vehicle treated) (p  0.01, N  3). We
conclude that NGF treatment increased activation of
p-Erk1/2 and p-p38 in the axons of DRG neurons.
Next, we asked if pErk1/2 were present in early endo-
somes in the axons of untreated animals. Most p-Erk1/2-
positive puncta were positive for Rab5B (78%  8%
[SEM], n  176 in 3 axons) (Figure 2M), TrkA (93% 
7%, n  159 in 3 axons) (Figure 2K), and Rap1 (Figure
2L). Trk and Rap1 also showed colocalization (Figure
2J). These immunostaining studies give evidence that
TrkA and p-Erk1/2 are present in early endosomes in
axons.
Evidence that Early Endosomess Are
Retrogradely Transported in DRG Neurons
The presence of p-Erk1/2 in early endosomes raised the
possibility that these organelles are used to retrogradely
Figure 4. Sciatic Nerve Chambermove NGF signals. Because the most likely mode of
A 4–5 cm section of sciatic nerve was placed between agarose gelretrograde transport of these endosomes involves mi-
slabs in a chamber in which the nerve ends were submerged incrotubule and dynein based transport (Brady, 1985;
wells containing the collection buffer described in Experimental Pro-
Goldberg, 1982), we tested whether or not TrkA-, p-Erk1/ cedures. The preparation was incubated at 37C (5% CO2) for 1–12
2-, and Rab5B-positive puncta were associated with hr, as noted for individual experiments.
these elements. p-Erk1/2-positive puncta in axons were
consistently aligned along the extended tubulin-positive
microtubule arrays (Figure 3A). The same pattern was axonal retrograde transport of TrkA in vitro (Hirashima et
al., 2000). These data are evidence that early endosomesseen for Rab5B (Figure 3B) and TrkA (Figure 3C). Dynein-
positive puncta were also distributed along axons, fre- could be used to retrogradely move NGF signals in the
axons of DRG neurons.quently closely associated, or colocalized, with puncta
for TrkA (Figure 3D; colocalization was 23.1% [5.3%,
N  3 axons, p  0.01]), p-Erk1/2 or Rab5B (data not 125I-NGF Is Retrogradely Transported in Axons
in a Sciatic Nerve Chambershown). As in axons, in cell bodies dynein was often
associated with TrkA (Figure 3E; 32.8%  5.0%, N  3, To characterize further the retrograde transport of NGF
signaling, we attempted to isolate signaling endosomesp  0.001), p-Erk1/2, or Rab5B (data not shown). The
dynactin protein complex mediates the interaction of from the axons of DRG neurons in the sciatic nerve.
While the ligated sciatic nerve offers an established sys-dynein with vesicle cargoes (Vaughan and Valle, 1995).
The p150Glued subunit of dynactin showed significant col- tem for examining transport, it involves certain disad-
vantages. First, it is difficult to separate retrogradelyocalization with that for TrkA in DRG neurons (Figure
3F; 37.0%  2.3%, N  3, p  0.001). transported membranes from other membranous struc-
tures. Second, the trauma induced by ligation causesTo show that Rab5-positive endosomes are moved
retrogradely in axons, DRG neurons in culture were ischemia and local injury that could induce changes in
signaling (Gurd, 1997; Nagatsu, 1978). Accordingly, wetransfected with a construct encoding Rab5A-GFP, a
protein that colocalizes with Rab5B and binds to EEA1, developed an alternative method, based on earlier stud-
ies (Viancour and Kreiter, 1993), in which the isolatedanother marker of early endosomes (Callaghan et al.,
1999). Using time-lapse imaging, Rab5A-GFP was seen sciatic nerve (i.e., the sciatic nerve chamber) was used
for studying axonal transport of vesicles (Figure 4).in bright puncta in both cell bodies and processes (i.e.,
axons) (Figure 3G). In cell bodies, puncta changed direc- NGF has been shown to be present in signaling endo-
somes isolated from PC12 cells (Howe et al., 2001). Totion frequently. In contrast, puncta in axons moved only
toward cell bodies. There were few pauses, and the test whether NGF transport could be used to mark these
organelles, we asked if NGF was retrogradely trans-average rate of movement was 0.34 m/s (0.09, n 
20 puncta), a speed compatible with earlier studies on ported in the isolated sciatic nerve. Ten hours after foot-
several GFP-positive puncta in the cell body were pseudocolored to show their movement. The background grid is composed of squares 10
m on a side. The movement of puncta was bi- or multidirectional and was marked by frequent pauses. In the lower images, a GFP-positive
puncta in an axon has been pseudocolored; the squares of the grid are 30 m on a side. In the graph, the number of changes in direction of
movement of individual puncta is plotted against the number examined. Rab5A-positive puncta in axons showed unidirectional movement
with only occasional pauses. The data are derived from observations on three neurons in one of three representative experiments.
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Figure 5. Retrograde Transport of 125I-NGF, p-Erk1/2, TrkA, and Signaling Proteins in the Sciatic Nerve Chamber
(A–D) Rats were injected in the right hindfootpad with radiolabeled NGF or in the left hindfootpad with vehicle (saline). Ten hours later,
a 4 cm section of sciatic nerve was dissected and placed in the sciatic nerve chamber (A). Radioactivity was measured in the proximal
and distal baths and by expressing the axoplasm of each of the five segments of the isolated nerve. There was no net movement of
NGF at 4C (B), but extensive transport occurred at 37C (B). 125I-NGF accumulated at thein vitro crush site (C). Disruption of micro-
tubules with nocodazole also blockedretrograde transport (C) (n  2 experiments for both crush and nocodazole). 125I-NGF
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pad injection of 125I-NGF, there was relatively uniform retrograde transport of NGF in vivo and in vitro (Claude
et al., 1982; Stockel et al., 1975; Hendry et al., 1975).labeling of the nerve section (data not shown), sug-
gesting that the 125I-NGF delivered to the target was
continuously present in an amount that supported trans- The Proximal Collection Contained Vesicles
and Membrane-Bound Proteins Characteristicport during the entire course of the experiment. When
a 4 cm section of nerve was cultured (Figure 5A) at 4C of Early Endosomes
To characterize the proteins and membranes that werefor 8 hr, radiolabeled NGF was present in relatively equal
amounts throughout the nerve (Figure 5B), with relatively retrogradely transported in vitro, we combined the con-
tents of the proximal bath with the axoplasm expressedlittle present in either the proximal or the distal baths.
In contrast, after 8 hr incubation at 37C, the proximal from the proximal 5 mm of segment 1; this constituted
the proximal collection. The distal bath and the axo-bath and the most proximal segment of the nerve (seg-
ment 1) (Figure 5B) contained 90% of 125I-NGF (counts plasm from segment 5 constituted the distal collection.
Equal amounts of total protein were present in the proxi-above background [SEM], n  number of nerves; proxi-
mal bath  503  133, n  3 [p  0.01]; segment 1  mal and distal collections (Figure 5E). EEA1, a protein
that marks early endosomes (Callaghan et al., 1999),431  77, n  3 [p  0.05]). The radiolabeled species
corresponded to intact NGF, since greater than 95% was present with Rab5B in the proximal collection (Fig-
ure 5E). In contrast, Rab4, which marks recycling endo-of counts were TCA precipitable. As evidenced by the
failure to detect increased NGF in the distal bath when somes (Sheff, 1999), was present essentially only in the
distal collection. We tested for proteins that mark otherthe chamber was held at 37C (Figure 2B), the movement
of NGF in the nerve was essentially exclusively retro- cellular compartments. BIP, an ER marker, was not de-
tected in either collection. We also failed to detect Rab7,grade.
NGF uptake into the nerve was due to a receptor- a marker of late endosomes (Rabinowitz et al., 1992),
or LAMP2, a protein found in lysosomes (Holcombe,mediated process, because the nerve was devoid of
labeled NGF when a 500-fold excess of unlabeled NGF 1993) (data not shown).
TrkA and p75NTR as well as Erk1/2 and p-38 were foundwas coinjected (data not shown). NGF retrograde trans-
port was dependent on intact axons since transport in both the proximal and distal collections (Figure 5E).
B-Raf was also present in both, confirming that it isis blocked by nerve crush (Figure 5C) and on intact
microtubules since injecting 20 l of a nocodazole solu- transported both anterogradely and retrogradely (Jo-
hanson et al., 1995, 1996). Of note, the activated formtion but not DMSO vehicle alone into the isolated nerve
also blocked transport (Figure 5C).When the nerve sec- of TrkA (i.e., p-TrkA) as well as p-Erk1/2 and p-p38 were
detected predominantly in the proximal collection.tion was held in vitro for only 4 hr, fewer counts (i.e.,
about one-half of those normally present at 8 hr [Figure These findings show that under the same conditions
used to detect retrograde transport of NGF to the proxi-5B]) were present in the proximal bath and segment 1
(Figure 5D). We then removed segment 1 and placed mal collection, this material also contained activated
signaling proteins and markers of early endosomes.the new proximal stump into a new proximal bath. After
an additional 4 hr of incubation, 125I-NGF was again de- The contents of the proximal collection did not appear
to be due to Schwann cell contamination. The amounttected in the proximal bath and in the most proximal
segment (i.e., segment 2) (Figure 5D). Taken together, of S100, a Schwann cell marker (Grafstein and Forman,
1980), in the proximal collection after 8 hr incubationthe results show that retrograde transport of NGF, initi-
ated by receptor-mediated uptake in the intact animal, was compared to the amount in a 5 mm segment of
nerve (i.e., the length of nerve from which axoplasmcontinues in the isolated sciatic nerve and is dependent
on temperature and on intact axons and microtubules. was expressed) that had not been incubated in vitro. A
sample representing 5% of the protein in the homoge-Our experiments allowed us to estimate the speed of
retrograde transport of 125I-NGF in the sciatic nerve. The nate contained much more S100 than a sample con-
taining 50% of the protein in the proximal collectionestimate derives from the evidence that transport ap-
pears to have persisted during all or most of the 8 hr (Figure 5F). Using the same analysis, much more Rab5B
was present in the proximal collection.period and that most of the counts were delivered to
the bath and proximal segment during this period. Since An OptiPrep density gradient (25%:20%:15%:10%:5%)
was used to purify organelles (modified from Sheff,during incubation essentially all of the counts present
in segment 4 had to move at least to segment 1, a 1999). Fractions were collected at each interface and in
the middle of the 20% element. As expected, Rab5Btransport rate of 3 mm/hr, or 0.8m/s, can be calculated.
This rate is consistent with measurements of axonal and EEA1 were present exclusively in fractions 4 and 5
continued to accumulate beyond 4 hr (D). (E) After 8 hr of incubation at 37C, the proximal collection and the distal collection were submitted
to SDS-PAGE. While they contained the same amount of total protein (n  3, result is mean  SEM normalized to the proximal collection),
p-TrkA (n  3), p-Erk1/2 (n  7), and p-p38 (n  2) were much greater in the proximal collection. (F) The amount of S100 present in the
proximal collection was minimal (n  2). (G) Immunoblot analysis of proteins in the proximal collection versus time of incubation. The amounts
of total protein (normalized to the 1 hr value; n  2 for each time point) and of each of the signaling proteins increased progressively with
time. The rates of accumulation for endogenous NGF (measured by ELISA), p-TrkA, and p-Erk1/2 are plotted with respect to the amounts
present at 1 hr of incubation (n  2 for each at each time point). The rates are comparable to the relative rate of accumulation of 125I-NGF,
as seen in (D). (H) At the initiation of incubation, p-TrkA and p-Erk1/2 were present uniformly in the nerve. Following incubation for 8 hr, they
accumulated only in the proximal collection (n  2). (I) As was true for NGF, the retrograde transport of p-TrkA and p-Erk1/2 were blocked
following nocodazole injection between segments 1 and 2 (n  2).
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Figure 6. Signaling Proteins Were Retrogradely Transported to the Proximal Collection in the Early Endosome-Containing Fractions: EM
Analysis of Transported Membranes
(A) The sciatic nerve was incubated for 8 hr in the chamber, and the proximal collection was fractionated in an Optiprep gradient, as described
in Experimental Procedures. Fractions were characterized by SDS-PAGE and immunoblotting or by analysis of silver staining gels (for total
protein) or by  counting (for 125I-NGF). Measures of total protein showed significant amounts in all fractions (the results are representative of
four experiments). Early endosomes were found in fractions 4 and 5, as marked by the presence of Rab5B and EEA1. Following 125I-NGF
injection into the footpad, as described above, the majority of the radiolabel was present in fraction 4 and 5. p-TrkA, Gab2, Rap-1, B-Raf,
p-MEK1/2, p-Erk1/2, p-p38, p-ATF2, and dynein were all present essentially exclusively in fractions 4 and 5. Erk1/2, the 85 kDa subunit of PI3K,
and p75NTR were also present in fractions 4 and 5 but not exclusively. Ras was only detected in fractions 1 through 3. The results for each
measurement are representative of two or three separate experiments. (B) The proximal tip of segment 1 and the middle of segment 3 were
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(Sheff, 1999) (Figure 6A). EM analysis of these fractions tion from animals injected with radiolabeled NGF was
subjected to fractionation. Fractions 4 and 5, which con-showed only uncoated vesicles (Figure 6B, fraction 4).
Membranes of similar size (Figure 6C) and description tained early endosomes, were found to contain virtually
all of the labeled NGF (i.e., 88%) (Figure 6A). To test ifaccumulated in the proximal and distal nerve segments
after incubation (Figure 6B, segment 1 and data not NGF was bound to TrkA, the pelleted membranes of the
proximal collection were lysed and an antibody againstshown), while very few vesicles were detected in the
middle segment (Figure 6B, segment 3), indicating both TrkA was used to immunoprecipitate the receptor and
any bound NGF. The TrkA immunoprecipitate containedthe anterograde and retrograde movement of vesicles
within the isolated nerve. Other structures were rarely 43% (10%, n  3) of the counts in the proximal collec-
tion, and when submitted to SDS-PAGE and autoradiog-detected in fractions 4 and 5; mitochondria were seldom
seen, multivesicular bodies (MVBs) were rare, and there raphy showed a single band at 13 kDa, the molecular
weight of the NGF monomer (Figure 6E). This band waswere no myelin fragments or other debris. IEM staining
of negatively stained grids confirmed that Rab5B was not present when radiolabeled NGF was injected to-
gether with a 500-fold excess of unlabeled NGF. Thepresent on membranes of the proximal bath (Figure 6D)
and provided further support that the proximal collection nonimmune IgG control immunoprecipitate showed no
counts above background (n  3). We conclude thatcontained early endosomes.
NGF was retrogradely transported within early endo-
somes, that it was intact, and that at least some of thisRab5B and the Activated Forms of TrkA, Erk1/2,
and p38 Were Retrogradely Transported NGF was bound to TrkA.
in the Isolated Nerve
Retrograde transport in the isolated nerve was further NGF-Related Signaling Proteins Were Present
in the Early Endosome-Containing Fractionscharacterized through biochemical studies. First, we
noted that there was progressive accumulation with time Recent studies have provided evidence that signaling
endosomes contain NGF, activated TrkA, and signalingof total protein in the proximal collection (Figure 5G),
pointing to the continued retrograde movement of pro- proteins of the Ras/Erk1/2 and Rap1/Erk1/2 pathways,
as well as other signaling proteins (Howe et al., 2001; Wuteins during the incubation. Western blotting with mark-
ers of early endosomes and NGF signaling showed time- et al., 2001). To determine whether or not the proximal
collection contained signaling proteins found in earlydependent accumulation of Rab5B, Trk, p-TrkA,
p-Erk1/2, and p-p38 (Figure 5G). endosomes, we subjected it to fractionation. Rab5B and
EEA1 in fractions 4 and 5 marked the presence of earlyPrior to incubation of the nerve segment, p-TrkA and
p-Erk1/2 were distributed throughout (i.e., 0 hr). Follow- endosomes (Figure 6A). Activated TrkA and several pro-
teins that mediate TrkA signaling were also detected ining 8 hr incubation at 37C, p-TrkA and p-Erk1/2 accu-
mulated in the proximal collection (Figure 5H) but not these fractions. We focused on proteins shown in vitro
to mediate TrkA signaling through the Rap1/MAPK path-in the distal collection. Nocodazole injection between
segments 1 and 2 resulted in the accumulation distal to way; Gab2, Rap1, B-Raf, p-MEK1/2, and p-Erk1/2 were
the site of injection of both p-TrkA and p-Erk1/2 (Figure all present in fractions 4 and 5 (Figure 6A). Remarkably,
5I). These findings show that p-TrkA and p-Erk1/2 are while Erk1/2 were present in all fractions, p-Erk1/2 were
retrogradely transported in the isolated nerve. Endoge- only present in fractions 4 and 5. In addition, p-p38
nous NGF, p-TrkA, and p-Erk1/2 accumulated in the and the activated form of ATF-2, a transcription factor
proximal collection at similar rates and at rates compa- activated by p38 (Fuchs, 2000; Raingeaud, 1996), were
rable to the rate of accumulation of radiolabeled NGF also present only in these fractions. Although the p85
(Figure 5 G). These data suggest that early endosomes subunit of PI3K was enriched in early endosome-con-
and proteins important for NGF signaling are retro- taining fractions, it was also present in other fractions
gradely transported in the isolated nerve and that this (Figure 6A). PLC- was not detected (data not shown).
transport continues during all or most of the period of Like TrkA, p75NTR was detected in fractions 4 and 5.
incubation in vitro. Although Ras was present in the proximal collection, it
was not found in fractions 4 and 5. The presence of
the dynein intermediate chain in fractions 4 and 5 isNGF Was Retrogradely Transported
in Membranes Bound to TrkA consistent with the immunostaining evidence linking
TrkA and early endosomes with this motor protein, asTo show whether or not NGF was retrogradely trans-
ported bound to its TrkA receptor, the proximal collec- documented above.
visualized by EM. Vesicles accumulated in segment 1 and were absent in segment 3. The results represent the findings in over 200 axons.
Vesicles present in fractions 4 and 5 were also examined by EM. (C). The cross-sectional areas for vesicles were calculated using NIH image.
The data reflect measurements on 1140 vesicles in segment 1 and in each of the two fractions examined. (D) The proximal collection was
transferred to metallic grids and incubated with antibodies raised against Rab5B, the intracellular domain (ID) of Trk, the p75NTR-ID, p-Erk1/2,
and p-p38. Antibodies were visualized using gold-labeled secondary antibodies. Note in the Trk-ID/Rab5B panel, a vesicle stained for both
Rab5B (5 nm particle) and TrkA (10 nm particle). There was no immunolabeling in experiments in which only the secondary antibody was
applied. The results are typical of many vesicles examined in each of two or three separate experiments. Note that the techniques used
resulted in flattened membranes with irregular edges, making it difficult to determine shape and size Nevertheless, the smallest dimension
of individual profiles measured about 60 nm, and the largest 500 nm. On occasion, we detected large, dark, irregularly shaped inclusions that
represented trapped metal. (E) Rats were injected in the footpad with 125I-NGF or with 125I-NGF plus a 500-fold excess of unlabeled NGF. Ten
hours later, the sciatic nerve was sectioned and placed in the chamber for 8 hr at 37C. The proximal collection was lysed and immunoprecipitated
with an antibody to TrkA (mTrk), and the sample was analyzed using SDS-PAGE followed by autoradiography for 2 weeks at 	80C.
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Figure 7. Evidence that Retrogradely Trans-
ported p-TrkA Was Associated with Proteins
of the Rap1/Erk1/2 Signaling Pathway: Sig-
naling from the Proximal Collection to
p-Erk1/2
(A) The TrkA immunoprecipitate from the
proximal collection contained B-Raf. Con-
versely, the B-Raf immunoprecipitate con-
tained p-TrkA. B-Raf was also present in the
Rap1 immunoprecipitate. For each experi-
ment, n  2. (B) The proximal collection was
submitted to an in vitro kinase reaction, and
the reaction mixture was probed to detect the
phosphorylated Elk-1 fusion protein (bottom
panel) and then reprobed to detect p-Erk1/2
(upper panel) (n  2 for each experiment). (C)
p-Erk1/2 immunoprecipitated from the proxi-
mal collection intensively phosphorylated the
Elk-1 construct in the in vitro kinase reaction.
To explore the possibility that signaling complexes of the NGF signal transported retrogradely in endo-
were present in the endosomes within the proximal col- somes. To test this, NGF or the vehicle was injected in
lection, we carried out immunoprecipitations for TrkA, the footpad of rats 10 hr prior to nerve isolation and
Rap1, and B-Raf. B-raf immunoprecipited with TrkA and incubation. NGF injection resulted in no significant
vice versa. The Rap1 immunoprecipitate contained change in the total protein present in the distal collection
B-Raf (Figure 7). These data point to the presence and (Figure 8A) or in the amounts of a number of signaling
to the association within membranes of the proximal proteins but did modestly increase the total protein
collection of TrkA and signaling proteins of the Rap1/ present in the proximal collection (1.36  0.12 [SEM]
p-Erk1/2 pathway. relative to vehicle, n  2). The effect was specific, as
there was no increase in Trk (1.08  0.17) or the dynein
Evidence that TrkA and Signaling Proteins Are intermediate chain (0.93  0.19) following NGF treat-
Exposed on the Surface of Endosomes ment. The Trk result may be explained by the use of an
Earlier studies showed that NGF can be carried retro- antibody that detects all Trks, not just TrkA. Also, many
gradely in MVBs (Sandow, 2000). While MVBs were rarely TrkA-expressing neurons may not have been exposed
seen in the proximal collection, it was important to deter- to injected NGF. NGF injection also resulted in increases
mine whether TrkA and the MAPKs could be detected on in NGF (1.83  0.41 p  0.05 relative to vehicle, n  3),
the surface of endosomal membranes. Using IEM, TrkA p-TrkA (2.72  0.4, p  0.05, n  2), Rap1 (3.56  1.09,
was detected only with antibodies directed at the intracel- p  0.05, n  2), p-Erk1/2 (2.43  0.6, p  0.05, n  3),
lular domain (Figure 6D). The same was true for p75NTR. and p-p38 (2.68 0.10, p 0.05, n 3) (Figure 8A). Only
When the proximal collection was treated with 0.01% Tri- modest increases were found for Erk1/2 (1.42, relative to
ton X-100 before applying antibodies, there was immuno- vehicle), p-38 (1.37), and Rab5B (1.44) (Figure 8A). To
reactivity to both the intracellular and the extracellular test the effect of increasing NGF in the target of innerva-
domains of TrkA and p75NTR (data not shown). In double tion on other signaling pathways, we tested the PI3K
IEM studies, vesicles immunoreactive for both Rab5B and pathway by assaying for the activated form of Akt (i.e.,
TrkA were detected (Figure 6D). Vesicles bearing pErk1/ pAkt) and noted increased p-Akt activity following NGF
2 and p38 were also identified. Thus, TrkA and signaling injection (Figure 8B), but only in the proximal collection.
proteins activated by NGF are present at the cytosolic To further test that target levels of NGF regulate retro-
surface of endosomes. grade signaling, we injected antibodies to NGF in the
target. We isolated the nerve 10 hr later and placed it
Elk-1 Was a Substrate for p-Erk1/2 in the chamber. Following anti-NGF injection, the levels
in the Proximal Collection of p-Erk1/2 were markedly reduced (0.36  0.10, p 
To examine the signaling capacity of the proteins in 0.01 relative to nonimmune serum-treated nerve, n  3)
the proximal collection, we tested whether Erk1/2 can as was the level of p-p38 (0.50  0.09, p  0.01, n  3)
phosphorylate an Elk-1-GST fusion protein in an in vitro (Figure 8C). Taken together, our data are evidence that
kinase assay. Elk-1 was phosphorylated by the proximal the level of NGF in the target regulates the amount of
collection (Figure 7B). As predicted by the relative NGF and the associated signaling proteins that are retro-
amounts of p-Erk1/2 in the proximal and distal collec- gradely transported.
tions, p-Erk1/2 immunoprecipitated from the proximal
collection induced a marked phosphorylation of Elk-1
Discussion(Figure 7C) more than did pErk1/2 from the distal col-
lection.
We tested the signaling endosome hypothesis, which
states that the retrograde signals of neurotrophic factorsAxonal Transport of p-Erk1/2, p-p38, and pAkt
are moved in endosomes that contain the ligand boundWas Dependent on the Concentration
to its activated receptor together with activated down-of NGF in the Target of Innervation
stream signaling proteins. Our studies of NGF signalingThe signaling endosome hypothesis predicts that NGF
levels in the target of innervation regulate the amount in DRG neurons in vivo provided evidence that NGF,
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Figure 8. NGF in the Target of Innervation
Modulated the Retrograde Transport of Sig-
naling Proteins and the Activity of Akt
(A) NGF injection in the footpad markedly in-
creased the amounts of p-TrkA, Rap1,
p-Erk1/2, and p-p38 in the proximal collec-
tion. The levels of Rab5B, Erk1/2, and p38
were increased modestly, but there was little
if any increase in Trk and dynein. (B) Follow-
ing NGF injection, p-Akt immunoprecipitated
from the proximal collection but not the distal
collection phosphorylated the GSK-3-GST
construct. (C) Compared to a control IgG,
anti-NGF injection in the target decreased
significantly the amounts of p-Erk1/2 and
p-p38 in the proximal collection. The results
are representative of three experiments.
TrkA, and the activated forms of Erk1/2 and p-38 are Snider, 2001, Morooka and Nishida, 1998). Because of
the technical challenges that attend biochemical studiespresent in early endosomes in both axons and neuronal
cell bodies. Using the isolated sciatic nerve, we col- using neurons, there is much less data for what role is
played by these signaling pathways in NGF-responsivelected and examined retrogradely transported mem-
branes. The studies reported here show that retro- neurons (Kaplan and Miller, 2000; Klesse and Parada,
1999). Studies on developing DRG neurons in vitro showgradely transported material (1) contains NGF bound to
TrkA; (2) contains activated TrkA as well as downstream that the kinases of the Erk1/2 pathway (i.e., c-Raf,
Mek1/2, and Erk1/2) are present in axons and cell bodiescomponents of the Rap1/Erk1/2, p38, and PI3K path-
ways; (3) displays the intracellular domains of TrkA and (Watson et al., 2001), that Erk1/2 is robustly activated
by NGF (Howe et al., 2001; Watson et al., 2001), andactivated Erk1/2 and p38 at the cytosolic surface of
membranes; (4) supports activated Erk1/2 signaling to that Erk1/2 activation leads to phosphorylation of the
transcription factor CREB (Watson et al., 2001). Erk1/2Elk-1 and pAkt signaling to GSK3 ; and (5) carries acti-
vated Erk1/2, p38, and Akt in amounts that are influ- activation mediates NGF-induced growth of processes
from both embryonic and mature DRG neurons (Liu andenced by the level of NGF present in the target of in-
nervation. These findings are compelling evidence for Snider, 2001). In contrast, NGF signaling leading to en-
hanced survival of neurons of the peripheral nervousthe existence of signaling endosomes. They suggest
that early endosomes are used to carry some NGF retro- system is mediated largely via activation of PI3K
(Crowder and Freeman, 1998; Klesse and Parada, 1999).grade signals.
What role p38 activation plays in these neurons is un-
known, but there is increasing recognition that p38 con-NGF Signals from the Target of Innervation
tributes to a variety of responses in neurons as well asto Activate MAPKs
other cells (Mao et al., 1999). These observations raiseTarget-derived NGF is known to play a critical role in
the possibility that Erk1/2 and p38 signaling contributethe survival, differentiation, and maintenance of DRG
to the maintenance of the neuronal phenotype of bothsensory neurons (Shadiack et al., 2001; Sofroniew et al.,
developing and mature DRG neurons. If so, their activa-2001). To test the signaling endosome hypothesis, we
tion may be linked to NGF’s role in maintaining manyfirst examined the effect of NGF injection in the target
facets of the nociceptive phenotype (Kimpinski et al.,of mature DRG neurons on Erk1/2 and p38. NGF in-
1997; Lindsay, 1988; Shu and Mendell, 1999; Watson etcreased by 50%–90% the amount of activated Erk1/2
al., 2001).and p38 in axons and cell bodies. In PC12, NGF activa-
Our findings for p-Erk1/2 differ from those of Segaltion of Erk1/2 and p38 cells is robust, long-lived, and
and coworkers, who in recent studies on compartmen-biologically significant (Klesse and Parada, 1999; Moro-
talized cultures of DRG neurons provided evidence thatoka and Nishida, 1998; Wu et al., 2001; Xing et al., 1998;
NT signaling induces activation of p-Erk1/2 in sensoryYork et al., 1998). Neurite outgrowth from PC12 cells is
under the influence of both Erk1/2 and p38 (Liu and axons but not in cell body (Watson et al., 2001). The
Neuron
80
discrepancy in findings is not explained, but very differ- 0.3 m/s (Hirashima et al., 2000). p75NTR has been re-
cently reported to be retrogradely transported at 0.4–1.6ent experimental paradigms were used. Of note, we did
not assess the extent of activation of Erk1/2 in axon m/s (Lalli and Schiavo, 2002). The findings for the rate
of retrograde transport of p75NTR and TrkA are thus con-terminals after NGF treatment and cannot rule out that
Erk1/2 activation may have been more robust in axon sistent with those reported here for Rab5.
terminals than in proximal axons and cell bodies (Wat-
son et al., 2001). While our findings provide no new NGF Was Transported in Isolated Sciatic Nerve
support for local controls on NGF signaling, they do give To test directly that early endosomes move the NGF
evidence that NGF signaling from the target of DRG signal in axons, we devised an isolated nerve prepara-
neurons activates Erk1/2 in the cell soma. tion to collect them. As a model for this, we used earlier
studies showing that membranes move actively in axons
in the dissected sciatic nerve (Viancour and Kreiter,Evidence that Early Endosomes Could Serve
1993). We reasoned that by placing each end of theas Signaling Endosomes
nerve into a tissue culture bath it might be possible toBecause in our studies NGF was delivered only to the
collect retrogradely and anterogradely directed mem-target of DRG neurons, the increased p-Erk1/2 and
brane traffic. Distinctly different patterns were detectedp-p38 seen in axons and cell bodies had to arise from
for the proteins that accumulated in the proximal (i.e.,signaling events that were initiated at axons terminals
retrograde) and distal (i.e., anterograde) collections;and then moved retrogradely. In exploring how the sig-
early endosomes, as marked by both Rab5B and EEA1,nals were moved, we noted that in a recent study
were enriched in the proximal collection. To test thep-Erk1/2 was present in clathrin-coated vesicles iso-
physiological properties of the isolated sciatic nerve,lated from NGF-treated PC12 cells (Howe et al., 2001).
we studied the retrograde transport of NGF and foundClathrin-coated signaling endosomes are an excellent
that it was transported in membranes and that its trans-candidate for the signaling endosomes that may be
port required the presence of intact microtubules. Theseformed in axon terminals, but since these vesicles are
observations pointed to the utility of the isolated nerveshort-lived intermediates, they are not suited for the
preparation for characterizing NGF trafficking and sig-long-distance transport of the NGF signal. Early endo-
naling.somes could play this role. Rab5, a marker of this organ-
elle, is present in axons and has been shown to mediate
axonal endocytosis (de Hoop et al., 1994). Moreover, Signaling Endosomes Were Collected
from the Isolated Nervethe pH profile of retrogradely transported endosomes
includes vesicles whose slightly acidic pH is that ex- Using the sciatic nerve chamber, we tested the signaling
endosome hypothesis, examining the possibility thatpected for early endosomes (Overly et al., 1995). Addi-
tional support for this view is that activated TrkA was early endosomes could serve this role. NGF was present
in membranes that fractionated with the properties ofrecently shown to be associated with activated Rap1
and p-Erk1/2 in the early endosomal compartment in early endosomes. In immunoprecipitation studies, NGF
was shown to be bound to TrkA. IEM studies confirmedPC12 cells (Wu et al., 2001). In the current study, we
characterized the localization of endogenous NGF, TrkA, that TrkA was present at the surface of early endosomes
and provided evidence that these membranes also dis-p-Erk1/2, p-p38, and Rab5B. All were found in discrete
puncta, and there was evidence of extensive colocaliza- played p-Erk1/2 and p-p38 on their cytosolic surface.
Significantly, p-TrkA, p-Erk1/2, and p-p38 were eachtion. It was noteworthy that about 80% of pErk1/2 pixels
were also positive for TrkA, raising the possibility that present in the early endosome-containing fractions, to-
gether with other components of these signaling path-endogenous NGF plays a major role in regulating signal-
ing to membrane-bound pErk1/2 in TrkA-expressing ways. Moreover, the retrograde transport of p-TrkA and
p-Erk1/2 was very similar to that of NGF with respectDRG neurons. In addition, TrkA, p-Erk1/2, and Rab5B
were routinely localized near microtubules and were to both rate of accumulation and dependence on intact
microtubules. In our studies using 125I-NGF, we calcu-found near or colocalized with both dynein, a motor
protein important for retrograde axonal transport lated a rate of retrograde transport of 3 mm/hr. This rate
is comparable to other reports of 125I-NGF transport in(Grafstein and Forman, 1980), and p150Glued, a compo-
nent of the dynactin complex. Given the recent finding vivo and in vitro (Claude et al., 1982; Hendry et al., 1975;
Stockel et al., 1975). The very similar rates for accumula-that TrkA is found in complex with the light and interme-
diate chains of dynein (Yano et al., 2001), evidence for tion of p-TrkA and 125I-NGF point to a rate for retrograde
transport of p-TrkA that also appoximates 3 mm/hr. Thisenrichment in early endosomes of subunits of both dy-
nactin and dynein (Habermann et al., 2001) and recent rate is comparable to some estimates of retrograde Trk
signaling in compartmented chambers in vitro (Ricciofindings in which p-Trk was colocalized with dynamitin
(Bhattacharryya et al., 2002), our observations encour- et al., 1997) but is far slower than that calculated by
Senger and Campenot (Senger and Campenot, 1997),aged the view that early endosomes could be used to
move the NGF signal retrogradely. This was supported who detected a very rapid appearance of TrkA in cell
bodies following NGF treatment of axons. While our datain time-lapse imaging studies showing that Rab-5 was
moved by retrograde transport in the axons of DRG are entirely consistent with those of Ginty and col-
leagues, the methods we employed do not allow us toneurons. Few studies have characterized the retrograde
movement of endosomes in neurons and none have rule out that a small amount of p-TrkA moves at a much
faster rate. In a direct test of the signaling potential ofexamined the movement of Rab5. However, in PC12
cells, retrogradely transported TrkA moved at a rate of isolated endosomes, we showed that p-Erk1/2 could
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phosphorylate Elk-1. In agreement with earlier in vitro and specific. However, certain observations suggest
that the signaling endosome hypothesis does not ex-studies, PI3K and pAkt were also present in the early
endosome-containing fractions (Kuruvilla et al., 2000) plain all aspects of retrograde NT signaling. Campenot
and colleagues have reported that at least one NGFand pAkt acted upon its GSK3 substrate. Taken to-
gether, the findings are strong evidence in support of the signal(s) does not require the endocytosis of NGF (Mac-
Innis and Campenot, 2002). In agreement with otherssignaling endosome hypothesis and raise the possibility
that early endosomes harbor NGF signaling complexes. (Miller and Kaplan, 2002), we think it is important to
explore further both the vesicle- and non-vesicle-basedAdditional studies using highly purified preparations will
be needed to document fully the signaling proteins that models for retrograde signaling. Indeed, recent observa-
tions pointing to the importance of dynein-dynactin de-reside in early endosomes. It is noteworthy that a differ-
ence with respect to the signaling of CCVs and early pendent retrograde transport for the viability and func-
tion of motor and DRG neurons (LaMonte et al., 2002;endosomes is already apparent. While in CCVs the Ras/
Erk1/2 pathway was represented (Howe et al., 2001), Ras Hafezparast et al., 2003; Puls et al., 2003) emphasize
the potential significance of continuing studies on retro-did not cofractionate with NGF, p-TrkA, or the activated
MAPKs in early endosomes. Instead, in early endo- grade signaling by neurotrophic factors.
somes the Rap1/Erk1/2 pathway appears to be the
Experimental Proceduresmeans by which NGF signals to Erk1/2.
Antibodies, Chemicals and Reagents, and Animals
NGF Levels in the Target Influence the Amount The antibodies used in these studies, as well as the chemicals and
of Retrogradely Transported p-TrkA reagents, are detailed in the Supplemental Data, under Experimental
Procedures (availabe online at http://www.neuron.org/cgi/content/and Activated MAPKs
full/39/1/69/DC1). Sprague-Dawley male rats were from CharlesTo ask whether the signaling properties of endosomes
River Laboratories (Wilmington, MA).would, as expected, respond to the level of NGF in the
target of innervation, we studied the material isolated
Media and Buffers
from nerves whose targets had been treated with NGF The buffers for perfusion, cryoprotection, and for blocking in prepa-
or with NGF antibodies. The results were striking in that ration for immunocytochemistry have been specified (Priestly). Col-
lection buffer for the sciatic nerve chamber was Dulbecco’s Modifiedthere were marked increases in the amount of p-TrkA,
Eagle’s Medium (DMEM) oxygenated and supplemented with 2 mMRap1, p-Erk1/2, p-p38, and pAkt when NGF was injected
EDTA, 1 mM orthovanadate, 2 mM PMSF, either with or without 1in the target. Conversely, substantially decreased sig-
mM NaF. All other buffers are listed in the Supplemental Data, undernals for p-Erk1/2 and p-p38 were detected in material
Experimental Procedures.
from nerves whose targets were treated with NGF anti-
body. Our findings complement earlier in vivo observa- Sciatic Nerve Dissection and Homogenization
tion for the influence of target-derived NGF on the retro- Rats were anaesthetized by CO2 inhalation and were decapitated,
and the sciatic nerve was harvested by making a distal cut at thegrade transport of TrkA (Ehlers et al., 1995). They are
branching of the tibial nerve and by a cut proximal 4–5 cm to thisalso consistent with the observation that NGF treatment
site. This section was placed in the collection buffer and transferredinduces the retrograde activation of Erk1/2 in DRG neu-
to the nerve chamber. In a separate experiment, a 5 mm section of
ron cell bodies (Averill et al., 2001). They differ from nerve was taken at mid-thigh and place in collection buffer supple-
findings using ligated sciatic nerve preparations which mented with 1% NP-40. It was homogenized using a Polytron PT
showed that NGF treatment decreased retrograde trans- 10/35 (Kinematica, Lucerne, Switzerland) (Delcroix et al., 1997).
port of p-Erk1/2 and p-ATF2. The cause for the discrep-
Sciatic Nerve Chamberancy is not known but may be due to the use of signifi-
Sterile 96 microwell plates (Becton Dickinson and Company, Frank-cantly different methods for monitoring retrograde
lin Lakes, NJ) were filled with 1% agarose gel disolved in sterile
transport of signaling. The current method avoids the H2O. Solidified agar was removed from two wells that were used
trauma associated with ligation and provides the oppor- for collecting transported material. Those wells were then filled with
tunity to control the environment in which signaling pro- 400 l collection buffer. Sciatic nerve sections were laid on top of
the agarose bed, and each end was submerged in a collection well.teins accumulates. Our findings show that changes in
Most of the exposed portion of the nerve was covered with a thinsignaling induced by NGF treatment are detected in both
slice (1 to 2 mm) of agarose gel. To prevent dehydration, the plateaxons and cell bodies. They provide a compelling case
lid was then placed on top of the chamber in such a way as to avoid
that the level of NGF in the target of innervation regulates contact with the nerve. The chamber was placed in an incubator at
the extent of signaling through endosomes. 37C, or at 4C, for 1–12 hr. To extract axoplasm, light pressure was
applied to the last 5 mm of the nerve section using the blunt edge
of a razor blade. The axoplasm was then mixed with 200 l ofSignaling Endosomes in Context: Models
fresh collection buffer or with the corresponding bath sample. Infor Retrograde Signaling
experiments using nocodazole injection, 20 l of a solution con-It is possible that NGF and other NTs may signal from
taining 5 mg/ml of Nocodazole, or DMSO as a control, was injected
targets of innervation through both vesicle- and non- using a Hamilton syringe (Hamilton; Reno, NV) between segments
vesicle-based mechanisms. This report and other recent 1 and 2, immediately after placing the nerve section in the chamber.
Nerve crushes were accomplished by applying constant pressurestudies have provided support for the vesicle-based
between segments 1 and 2 with finely tipped forceps for 20 s.delivery of the NT retrograde signal (Bhattacharryya et
al., 2002; Grimes et al., 1997; Howe et al., 2001; Kuruvilla
NGF and Anti-NGF Treatmentset al., 2000; Tsui-Pierchala and Ginty, 1999; Watson et
Lyophilized NGF was resuspended in PBS (pH 7.0) containing 0.05%
al., 1999). We conclude that some NT signals are carried acetic acid. The rat right hindlimb was briefly immobilized and 6 l
by endosomes, and we suggest that these organelles of the NGF-containing solution was injected subcutaneously at each
of 10 sites in the right hindfootpad (total dose of 0.14 mg/kg). Simi-are suited for conveying information that is both robust
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larly, we injected 10 l of goat anti-NGF, a dose adequate to neutral- an antibody to phospho-Akt conjugated to agarose beads (Cell Sig-
naling Technology). Beads were washed twice in lysis buffer, oneize at least 50 times the amount of endogenous NGF in the footpad.
As a control the left hindfootpad of the animal was injected identi- time in 1
 kinase buffer, and then resuspended into 50 l 1
 kinase
buffer, containing 2 g of recombinant GSK-3-GST fusion protein.cally but with a solution containing 0.05% acetic acid in PBS (pH
7.0) or with 10 g of nonimmune goat IgG. Iodination of NGF was The samples were warmed to 30C for 30 min. SDS-PAGE loading
buffer (25 l) was then added to stop the reaction, and the samplescarried out as described (Howe et al., 2001). Typical iodinations
produced NGF with a specific activity of 150–200 cpm/pg. 5 Ci of were then boiled and subjected to SDS-PAGE and immunoblotting
for GSK-3 (1:1000) as above.125I-NGF, containing 61–110 ng of NGF, was injected as above except
that five injections of 4–5 l each were used. In all cases, 8–12 hr
after injection, the sciatic nerve chamber was prepared, as de- Immunocytochemistry
scribed above. The transport of 125I-NGF was studied using the con- For quantification of immunoreactivity post NGF treatment, rats
tents of the proximal and distal baths as well as the axoplasm were anaesthetized with 0.3 ml/kg of a xylazine/ketamine cocktail
collected from individual nerve segments. The bath and axoplasm (Stanford University Veterinary Services, Palo Alto, CA). Perfusion,
samples were TCA precipitated (7% TCA, 7 mg/ml DOC, 20 min postfixation, cryoprotection, and the preparation and mounting of
at 4C). Radioactivity in the pellets was measured in a  counter cryostat sections used established methods (Priestly). Sections on
(Beckmann  4000). We showed that NGF injections were not associ- Superfrost glass slides (VWR Scientific, Media, PA) incubated in
ated with appreciable systemic spread. Ten hours after 125I-NGF blocking solution for 1 hr at room temperature, washed three times
injection in the right hindfootpad, there were no cpm above back- for 5 min each in PBS, and incubated in primary antibody overnight
ground in the axoplasm of the left sciatic nerve harvested exactly in PBS plus 0.1% Triton-X-100 at 4C. Primary antibodies were used
in the same manner as for the right side. at concentrations recommended by the manufacturers. Sections
were washed in PBS three times for 5 min each and incubated with
Characterization of Signaling Proteins in the Proximal fluorescein-conjugated secondary antibodies (1:500) for 1 hr at room
and Distal Collections temperature. Sections were then washed in PBS three times for 10
The proximal and distal collection were briefly centrifuged (Eppen- min each, once briefly in H2O.
dorf centrifuge [5415C]) (10,000 rpm for 1 min) to remove large Except for Figure 1, for imaging DRG cells, DRGs were dissected
debris. In some cases, the supernatants were fractionated, as de- and the surrounding capsule was removed. A pair of fine forceps
scribed elsewhere (Wu et al., 2001). Both fractionated and nonfrac- was then used to move cells onto a charged Superfrost glass slide.
tionated samples were brought to a final concentration of 1% Triton For axon visualization, the sciatic nerve was freshly removed and
X-100, vortexed, and incubated at 4C for 10 min. They were then placed in a saline solution. The perineurium was then removed, and
TCA precipitated and analyzed by SDS-PAGE and immunoblotting axons were displaced onto a charged Superfrost glass slide. Cell
using ECL for detection, as described (Wu et al., 2001). For quantita- and axons were fixed in methanol as described (Howe et al., 2001).
tion of immunoblots, the exposed ECL-sensitive film was analyzed Immunostaining proceeded as above. When double immunostaining
by densitometry (Duoscan f40, Agfa [Ridgefield Park, NJ]) using NIH was performed, a second primary antibody was added sequentially
image (NIH, Bethesda, MD). Total protein content was evaluated by and sections were incubated overnight at 4C. Secondary antibodies
submitting the TCA-precipitated sample to SDS-PAGE followed by were applied together for 1 hr at room temperature before washing
silver staining, using the protocol recommended by the manufac- overnight in PBS at 4C. Images were captured using a Nikon Eclipse
turer (Geno Technology, Inc [St. Louis, MO]). Total protein content E800 microscope and a Radiance2000 confocal scanning system
was determined using densitometry, as described above. (Bio-Rad, Hercules, CA) (Howe et al., 2001).
To quantitate colocalization, confocal images were analyzed us-
Immunoprecipitation ing Laserpix (Bio-rad, Hercules, CA). The detailed methods for this
The proximal collection was also submitted to immunoprecipitation analysis are given in the Supplemental Data under Experimental
after initial centrifugation, as above. The supernatant was collected Procedures (http://www.neuron.org/cgi/content/full/39/1/69/DC1).
and lysed with a “Cell Lysis Buffer” (see Supplemental Experimental
Procedures at http://www.neuron.org/cgi/content/full/39/1/69/ Live Imaging
DC1). Protein-A or protein-A/G beads were washed twice in the DRG cells isolated from Sprague-Dawley rats (E15–E16) were plated
same buffer. Antibodies raised against B-Raf, TrkA, or Rap1 (10 g at a density of 150,000 cells per well in 6 well plates on 22 

each) were incubated with or without the proximal collection in the 22 mm collagen-coated glass coverslips in maintenance medium
presence of Protein-A or protein-A/G beads overnight at 4C. Beads overnight (37C, 5% CO2). DRG neurons were selected by applying
were pelleted by brief centrifugation and then washed twice with antimitotic medium to cultures for 2 days. Prior to transfection, cells
cold TET containing 250 mM NaCl, followed by two washes in cold were rinsed three times with fresh DMEM and placed in maintenance
10 mM Tris-HCl (pH 7.5) containing 5 mM EDTA. The supernatant medium overnight. Neurons were transfected with pEGFP-hRab5A
was analyzed by SDS-PAGE and immunoblotting. Primary and sec- (in a pEGFP-C3 vector a gift of Marino Zerial) at a DNA concentration
ondary antibodies were used at the dilutions suggested by the man- of 6 g/well, according to the methods of Xia et al. (1996). Following
ufacturer.
transfection, cells were returned to the incubator for 2 days. Trans-
fection efficiency was 10%. Cells were imaged as follows: coverslips
Elk-1 Phosphorylation Assay
were removed from wells and flipped cell-side down onto a well of
Fifty microliter samples of proximal and distal collections were di-
a 24 well plate (Becton Dickson) that was filled with Leibovitz L-15
luted with 50 l of 2
 kinase buffer (4C), containing 2 g of a
medium (37C). The bottom of the coverslip was dried with a cotton
recombinant Elk-GST fusion protein (Cell Signaling Technology).
swab. Images were collected every 10 s at room temperature with
The mixture was warmed to 30C for 30 min. The reaction was
a confocal microscope as described above.
terminated by adding 25 l of SDS-PAGE loading buffer, boiled,
then subjected to SDS-PAGE and immunoblotting for p-Elk (1:1000).
EM and ImmunoEMFor some studies, the proximal and distal collections were brought
The details are listed in the Supplemental Data, under Experimentalto 1
 lysis buffer (see Supplemental Experimental Procedures at
Procedures (http://www.neuron.org/cgi/content/full/39/1/69/DC1).http://www.neuron.org/cgi/content/full/39/1/69/DC1) and immuno-
precipitated overnight (4C) with an antibody to p-Erk1/2 conjugated
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